Cephalon Acquires Generic Drug maker Mepha
By Taskin Ahmed
PharmaDeals Review: Vol 2010 Issue 2 (Table of Contents)
Published: 8 Feb-2010
DOI: 10.3833/pdr.v2010i2.1309 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
US biopharma company Cephalon acquired the Swiss-based generic pharmaceutical company Mepha AG for US$590 M thereby throwing open the doors to markets in Europe, Africa and the Middle East...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login on the top right purple box.
Copyright: PharmaVentures Ltd
Last Issue PDF
RSS